NETRIS Pharma is a clinical-stage immuno-oncology company that develops targeted therapies for the treatment of cancer. It provides vitro and in vivo research, preclinical practices for manufacturing drugs for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma cancer.